NEW YORK (Reuters) - Eli Lilly said on Thursday U.S. regulators approved the use of Cymbalta, its blockbuster anti-depressant drug, for chronic musculoskeletal pain, including lower back pain and ...

Many with peripheral neuropathy use medications like Gabapentin, Lyrica, or Cymbalta for relief, but these only mask symptoms instead of treating the cause. While they may temporarily reduce pain, ...

Co announces Data from a pooled analysis of three studies suggest that in patients with pain caused by diabetic nerve damage, or diabetic peripheral neuropathy, who are treated with Cymbalta ...

Eli Lilly and Co. said its depression drug Cymbalta showed some effectiveness against chronic low back pain, according to data presented today in Spain. The study gives Lilly evidence to perhaps get ...